C12N 2740/10063
By chemical treatment
Official title: by chemical treatment
C12N2740/10063 (By chemical treatment) appears on 3 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 4
- Assignees
- 3
- Inventors
- 20
- Latest grant
- 22 Aug 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 1 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Mechanical method of maintaining narrow residence time distributions in continuous flow systems22 Aug 2023US 11,732,003 B2EMD Millipore Corporation
- Methods for producing peptides including HERV-W envelope motifs and for producing antibodies specific for the peptides7 Aug 2018US 10,040,829 B2Biomerieux
- Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein24 Jan 2006US 6,989,263 B1The United States of America, as represented by the Secretary, Department of Health and Human Services
- Detergent for viral inactivation6 Feb 2025US 2025/0040546 A1
- Mechanical Method Of Maintaining Narrow Residence Time Distributions In Continuous Flow Systems4 Jun 2020US 2020/0172568 A1EMD Millipore Corporation
- Peptide domain required for interaction between the envelope of a virus pertaining to the herv-w interference group and an hasct receptor31 Mar 2016US 2016/0090402 A1Biomerieux
- Peptide Domain Required For Interaction Between The Envelope of a Virus Pertaining to The Herv-W Interference Group and an Hasct Receptor11 Jun 2009US 2009/0148454 A1Biomerieux
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.